ZEUS HYGIA LIFE SCIENCES Pvt. Ltd - Comprehensive Analysis Report

Summary

ZEUS HYGIA LIFE SCIENCES Pvt. Ltd. is a science-driven nutraceutical company headquartered in Hyderabad, India, specializing in the development and manufacturing of specialty nutraceutical ingredients and nature-identical food colors. Founded by technical experts with experience in the nutraceutical and pharmaceutical industries, the company aims to develop, manufacture, and market innovative nutraceutical ingredients for various industries including nutraceutical, pharmaceutical, cosmeceutical, food, feed, FMCG, and beverage. ZEUS HYGIA envisions becoming an international contract research organization, providing clinical services and formulation technology support to its clients while maintaining ethical and transparent business practices. The company's mission involves introducing traditional Indian herbs to the global stage through scientific backing and clinical studies.

1. Strategic Focus & Objectives

Core Objectives

Develop and manufacture innovative nutraceutical ingredients.

Introduce traditional Indian herbs to the global stage with scientific backing and clinical studies.

Develop platform technologies and branded ingredients targeting specific therapeutic segments.

Improve the solubility and bioavailability of poorly soluble actives to increase bio-efficacy, potency, and bioavailability.

Provide clinical services and formulation technology support to its clients.

Specialization Areas

Development of specialty nutraceutical ingredients.

Manufacturing of nature-identical food colors.

Improving the solubility and bioavailability of poorly soluble actives.

Creating differentiated products that address therapeutic gaps in the nutraceuticals segment.

Target Markets

Nutraceutical industry.

Pharmaceutical industry.

Cosmeceutical industry.

Food, feed, FMCG, and beverage industries.

2. Financial Overview

Funding History

Total funding to date: $2.39M.

Detailed breakdown of recent funding rounds:

Date: April 7, 2025

Amount: $2.34M (Seed funding round)

Key Investors: NABVENTURES (largest institutional investor)

Fund Utilization: Not specified.

Impact on company growth: Latest valuation of Zeus Hygia is ₹86.5Cr as of April 7, 2025.

3. Product Pipeline

Key Products/Services

Focus on developing branded ingredients with BioSOLVE Technology to address unmet areas in prostate and cardiac health.

Grantria®:

Description: A pomegranate extract targeting anti-aging and beauty.

Development stage: Launched and supported by clinical studies.

Target market/condition: Anti-aging, beauty, reducing facial wrinkles, and improving skin conditions.

Key features and benefits: Reduces facial wrinkles (crow's feet) and improves skin radiance.

Gremin®:

Description: A patented formulation for sports and active nutrition using dual-extract embedding technology.

Development stage: Launched.

Target market/condition: Sports and active nutrition, muscle recovery, reducing muscle pain, and enhancing stamina and endurance.

Key features and benefits: Fastens muscle recovery, reduces muscle pain, and enhances stamina and endurance.

Stadice®:

Description: An enriched Mangifera Indica extract.

Development stage: Launched.

Target market/condition: Cognitive wellness.

Gevalin®:

Description: A fruit pulp powder.

Development stage: Launched.

Target market/condition: Acidity and gastric wellness.

4. Technology & Innovation

Technology Stack

BioSOLVE Technology: A patent-pending delivery system that enhances the bioavailability, efficacy, and potency of water-insoluble active ingredients. Improves water solubility, dissolution, and particle uniformity.

BioFusion Technology: A proprietary platform that enables the encapsulation of bioactives with a unique bio potentiator using encapsulation technology. Creates molecular dispersions of bioactives in food-grade media, ensuring synergistic properties and stability.

ADOP (Advanced Oil to Powder) Technology: A clean-label process that infuses multiple bioactives in powder and oil form into a plant-based carrier, yielding a free-flowing powder without oil leaching.

Insolib Technology: Addresses the limitations of herbal extracts which tend to be unstable in acidic environments and leads to poor invivo absorption.

5. Leadership & Management

Executive Team

Arunkanth Krishnakumar:

Position: Co-Founder & Director.

Professional background: Master's degree in pharmacy, experience with companies like Cipla, Aurobindo Pharma, and Celltrion Inc.

Key Contributions: Not specified.

Shankaranarayanan Jeyakodi:

Position: Co-Founder & Director - Technical Operations.

Professional background: Not specified.

Key Contributions: Not specified.

6. Competitive Analysis

Major Competitors

OmniActive:

Overview: Not specified.

Focus Areas: Not specified.

Technological Capabilities: Not specified.

Notable Achievements: Not specified.

Competitive Positioning: Not specified.

Botanic Healthcare:

Overview: Not specified.

Focus Areas: Not specified.

Technological Capabilities: Not specified.

Notable Achievements: Not specified.

Competitive Positioning: Not specified.

Nutrileads:

Overview: Not specified.

Focus Areas: Not specified.

Technological Capabilities: Not specified.

Notable Achievements: Not specified.

Competitive Positioning: Not specified.

7. Market Analysis

Market Overview

The nutraceutical industry is experiencing growth, driven by consumer preferences and scientific advancements.

Key trends include increased demand for plant-based and organic supplements, personalized nutrition solutions, and the integration of technology for health tracking.